Source:http://linkedlifedata.com/resource/pubmed/id/11246230
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2001-3-14
|
pubmed:abstractText |
Individuals with neurofibromatosis 1 (NF1) develop low-grade astrocytomas at an increased frequency. To gain insight into the function of the Nf1 gene product as a growth regulator for astrocytes, we examined mice heterozygous for a targeted Nf1 mutation. In our previous studies, we demonstrated increased numbers of proliferating astrocytes in Nf1 heterozygote (Nf1+/-) mice in vivo. We now show that cultured Nf1+/- astrocytes exhibit a cell-autonomous growth advantage in vitro associated with increased p21-ras pathway activation. Furthermore, we demonstrate that Nf1+/-;wild-type N-ras mice have a similar astrocyte growth advantage in vitro and in vivo as either oncogenic N-ras or Nf1+/-; oncogenic N-ras mice. Lastly, mice heterozygous for targeted defects in both Nf1 and p53 as well as Nf1 and Rb exhibit 3- and 2.5-fold increases in astrocyte proliferation in vivo, respectively, suggesting that abnormalities in Nf1- and p53/Rb-regulated pathways cooperate in the heterozygous state to confer a growth advantage for brain astrocytes. Collectively, these results provide evidence for a cell-autonomous growth advantage in Nf1+/- astrocytes and suggest that some of the brain pathology in individuals with NF1 might result from reduced, but not absent, NF1 gene function.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Neurofibromin 1,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins p21(ras),
http://linkedlifedata.com/resource/pubmed/chemical/Retinoblastoma Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0894-1491
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2001 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
314-23
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11246230-Animals,
pubmed-meshheading:11246230-Astrocytes,
pubmed-meshheading:11246230-Astrocytoma,
pubmed-meshheading:11246230-Brain Neoplasms,
pubmed-meshheading:11246230-Cell Count,
pubmed-meshheading:11246230-Cell Division,
pubmed-meshheading:11246230-Cells, Cultured,
pubmed-meshheading:11246230-Heterozygote,
pubmed-meshheading:11246230-Mice,
pubmed-meshheading:11246230-Mice, Knockout,
pubmed-meshheading:11246230-Neocortex,
pubmed-meshheading:11246230-Nerve Tissue Proteins,
pubmed-meshheading:11246230-Neurofibromin 1,
pubmed-meshheading:11246230-Proto-Oncogene Proteins p21(ras),
pubmed-meshheading:11246230-Retinoblastoma Protein,
pubmed-meshheading:11246230-Tumor Suppressor Protein p53
|
pubmed:year |
2001
|
pubmed:articleTitle |
Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes.
|
pubmed:affiliation |
Department of Neurology, Washington University School of Medicine, 860 S. Euclid Avenue, St. Louis, MO 63110, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|